DaVita Slides as Investors Appear to De-Risk Ahead of Earnings

2026-10-20

Investivoq PriceTracker

DaVita Inc. (DVA) is down 5.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely explanation is pre-earnings de-risking rather than a clearly disclosed negative company event. DaVita announced on October 19 that it will report third-quarter 2026 results on October 29, and recent public company channels do not show a fresh adverse filing or guidance cut that would obviously explain a one-day drop. This could be because traders are locking in gains after a strong run earlier this year and repositioning ahead of the next earnings update. ([investors.davita.com](https://investors.davita.com/news-releases/?o=1185&sessionGUID=383dd8bb-4517-e0c5-8d1c-a69614782588&webSyncID=bd72a83e-91ad-a982-a00b-dac625683bb6&utm_source=openai))

Details:

DaVita’s investor site listed a new item on October 19 scheduling its third-quarter 2026 investor conference call for October 29 after the market closes. ([investors.davita.com](https://investors.davita.com/news-releases/?o=1185&sessionGUID=383dd8bb-4517-e0c5-8d1c-a69614782588&webSyncID=bd72a83e-91ad-a982-a00b-dac625683bb6&utm_source=openai))

The company’s recent investor news flow has been operationally positive, including research presentations at ASN Kidney Week on October 15, with no obvious same-day negative announcement visible in the latest releases. ([investors.davita.com](https://investors.davita.com/2026-10-15-davita-brings-new-clinical-research-to-asn-kidney-week-2026-advancing-evidence-for-the-next-era-of-kidney-care/?utm_source=openai))

The SEC filings page visible through the investor site mainly shows routine filings in recent weeks, such as insider Form 4 disclosures, rather than a newly posted material warning. ([investors.davita.com](https://investors.davita.com/sec-filings/?cat=1&filer=Ticker%3ADVA&utm_source=openai))

The stock had already been volatile, rising 4.57% on October 15 and entering October 20 up 64.6% year to date, which supports the idea of profit-taking ahead of earnings. ([marketbeat.com](https://www.marketbeat.com/stocks/NYSE/DVA/chart/?utm_source=openai))

Sources:

DaVita Investor Relations, SEC, MarketBeat

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$DVA Insider Trading Activity

$DVA insiders have traded $DVA stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $DVA stock by insiders over the last 6 months:

HATHAWAY INC BERKSHIRE has made 0 purchases and 2 sales selling 1,403,356 shares for an estimated $219,377,971.
JAVIER RODRIGUEZ (Chief Executive Officer) has made 0 purchases and 2 sales selling 69,407 shares for an estimated $14,532,108.
DAVID PAUL MAUGHAN (Chief Operating Officer, DKC) has made 0 purchases and 2 sales selling 20,529 shares for an estimated $4,089,742.
KATHLEEN ALYCE WATERS (Chief Legal & Pub. Affairs Off) has made 0 purchases and 2 sales selling 15,405 shares for an estimated $3,210,376.
JAMES O HEARTY (Chief Compliance Officer) sold 15,000 shares for an estimated $2,909,745

To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

$DVA Hedge Fund Activity

We have seen 295 institutional investors add shares of $DVA stock to their portfolio, and 283 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BERKSHIRE HATHAWAY INC removed 1,220,376 shares (-4.1%) from their portfolio in Q2 2026, for an estimated $271,509,252
BANK OF AMERICA CORP /DE/ added 410,940 shares (+170.5%) to their portfolio in Q2 2026, for an estimated $91,425,931
NEUBERGER BERMAN GROUP LLC added 393,492 shares (+74.0%) to their portfolio in Q2 2026, for an estimated $87,544,100
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 365,569 shares (+inf%) to their portfolio in Q2 2026, for an estimated $81,331,791
WOODLINE PARTNERS LP removed 350,172 shares (-77.3%) from their portfolio in Q2 2026, for an estimated $77,906,266
UBS GROUP AG removed 345,349 shares (-53.1%) from their portfolio in Q2 2026, for an estimated $76,833,245
FREESTONE GROVE PARTNERS LP removed 315,157 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $70,116,129

To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

$DVA Government Contracts

We have seen $181,090,169 of award payments to $DVA over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

EXPRESS REPORT: FY 26 NOVEMBER NDSC EXPRESS REPORT: $121,425,309
EXPRESS REPORT: FY 26 OCTOBER NDSC EXPRESS REPORT: $26,893,447
ON-SITE DIALYSIS SERVICES: $1,145,928

To track government contracts to publicy traded companies, check out Investivoq's government contracts dashboard. You can access data on government contracts through the Investivoq API government contracts endpoint.

$DVA Analyst Ratings

Wall Street analysts have issued reports on $DVA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Deutsche Bank issued a "Buy" rating on 05/06/2026

To track analyst ratings and price targets for $DVA, check out Investivoq's $DVA forecast page.

$DVA Price Targets

Multiple analysts have issued price targets for $DVA recently. We have seen 5 analysts offer price targets for $DVA in the last 6 months, with a median target of $218.0.

Here are some recent targets:

Andrew Mok from Barclays set a target price of $218.0 on 07/09/2026
Ryan Langston from TD Cowen set a target price of $201.0 on 05/11/2026
David Macdonald from Truist Securities set a target price of $205.0 on 05/08/2026
A.J. Rice from UBS set a target price of $235.0 on 05/07/2026
Pito Chickering from Deutsche Bank set a target price of $220.0 on 05/06/2026

This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.